About York Instruments
York Instruments was a Healthcare company based in York (United Kingdom) founded in 2015. It develops innovative magnetoencephalography technologies for neuroimaging. It operates on a B2B model. The company has 37 employees. The company is recorded as dissolved. Its focus areas include Medical Devices, Neuroimaging and Magnetoencephalography. Its legal entity is YORK INSTRUMENTS LTD. Its competitors include Inscopix, Neurotrack, Brainomix, Artiria and Luciole Medical and 5 more; 10 of its 10 listed competitors have raised funding.
Company details
York Instruments develops innovative magnetoencephalography technologies for neuroimaging, focusing on providing healthcare solutions, developing medical devices, neuroimaging, and magnetoencephalography. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters York, United Kingdom
- Employees 37
- SectorsHealthcare
- Website york-instruments.com
- Social X Facebook
- Legal Name York Instruments Ltd
- InvestorsHSBC
& 1 more
- Employee Count37
Funding Insights of York Instruments
- Total Rounds 2
- First Round $88,816
(Jan 2019)
- Investors Count 2
All 2 funding rounds of York Instruments with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | – | Debt – Conventional | – | – | |
| Jan 2019 | $88,816 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in York Instruments
York Instruments has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HSBC and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Universal banking and financial advisory services are provided globally. | 1865 | hsbc.com | London, United Kingdom | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for York Instruments
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of York Instruments
3 dated milestones of York Instruments across 4 years, from founding to its latest funding, stage changes and deals.
- Founded York Instruments is founded.
- Funding First funding round of $89K.
- Funding Latest funding round, Debt – Conventional,.
Competitors of York Instruments
York Instruments has 10 listed competitors in our database, 10 of them funded. They include Inscopix, Neurotrack, Brainomix, Artiria and Luciole Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inscopix.com | 2011 | Palo Alto, United States | $10M | 68 | Miniscope platforms are developed for decoding brain neural circuits. | |
| neurotrack.com | 2012 | Redwood, United States | $57.81M | – | Neurological disorders are diagnosed using eye-tracking assessment tools. | |
| brainomix.com | 2010 | Oxford, United Kingdom | $52.78M | 29 | AI-powered imaging biomarkers are provided for precision medicine applications. | |
| artiria-medical.com | 2019 | Lausanne, Switzerland | $9.19M | – | Micro-navigation systems for stroke surgery are developed. | |
| luciolemedical.com | 2018 | Zurich, Switzerland | $5.5M | – | Brain monitoring devices and analytics platforms are developed and provided. | |
| cndlifesciences.com | 2017 | Phoenix, United States | $37.51M | 22 | Provider of a neurological disease diagnostic tool for providers | |
| pdneurotechnology.com | 2015 | London, United Kingdom | $93.34M | 32 | A wearable device is developed to monitor Parkinson's movement disorders. | |
| neurokaire.com | 2017 | Kearny, United States | $20M | – | Platform offering personalized treatment for psychiatric and neurological conditions | |
| darmiyan.com | 2015 | San Francisco, United States | $10.09M | – | Platform for presymptomatic diagnosis of neurodegenerative disorders | |
| manusneuro.com | 2008 | Motherwell, United Kingdom | $5.79M | 6 | Devices for neuromotor impairment biomarkers are provided. |
Detailed competitors of York Instruments
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
10 companies that operate in the same segment as York Instruments (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about York Instruments
Complete news archive for York Instruments
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about York Instruments
York Instruments was founded in 2015 and raised its 1st funding round 4 years after it was founded.
York Instruments is headquartered in York, United Kingdom.
York Instruments has 37 employees.
York Instruments develops innovative magnetoencephalography technologies for neuroimaging, focusing on providing healthcare solutions, developing medical devices, neuroimaging, and magnetoencephalography. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
York Instruments's top competitors include CND Life Sciences, NeuroKaire and Inscopix.
York Instruments has 2 investors. Key investors include HSBC, and European Union.
York Instruments operates through York Instruments Ltd.